Old new coronavirus

Abstract

The main biological characteristics of Coronaviridae viruses, including viruses, severe acute respiratory syndrome and Middle East respiratory syndrome, are presented. The features of immunopathogenesis associated with these infections and their differences from the infection 2019-2020 are analyzed. It is believed that the modern incidence of upper respiratory tract in adults, associated with coronaviruses, is between 10 and 30%. Coronaviruses are ecologically diverse, with the greatest diversity in bats, suggesting that they are the main reservoirs of coronaviruses. Research into the genome of the new coronavirus - 2019-nCoV has shown that it has about 80% nucleotide identity with original viruses of severe acute respiratory syndrome and the ability to bind to angiosine-transforming receptors еnzyme 2. This, along with the high genetic proximity of coronaviruses, indicates their overall origin and overall probable source. However, the receptors of the angiosin-transforming enzyme 2 are the key that gives access to the cell even with low infecting activity. It has been shown that the main diagnostic methods to increase the specificity of detection of a new coronavirus should be variants of polymerase chain reaction and immunoblotting. However, there is still a lot of unknown related to the life of the 2019-nCoV virus. There is a clear identification and comparison of the genomes of the virus in different countries. Identify those genetic inserts that allow the virus to escape from the control of the immune system and turn into a hypervirulent strain. Proving or disprove the possibility of the 2019-nCoV virus is altering its genetic and antigenic potential in different animal species and becoming a new type of virus.

Keywords

coronaviruses / immune system / receptors / strain / genome / syndrome / antigens / virulence / severe acute respiratory syndrome / middle east respiratory syndrome

References

[1] Каротяев, А.И. Медицинская микробиология, иммунология и вирусология / А.И. Каротяев, С.А. Бабичев. – СПб.: СпецЛит, 2010. – 715 с.

[2] Москалев, А.В. Общая иммунология с основами клинической иммунологии / А.В. Москалев, В.Б. Сбойчаков, А.С. Рудой. – М.: ГЭОТАР-Медиа, 2015. – 351 с.

[3] Сбойчаков, В.Б. Лабораторная диагностика вирусных инфекций / В.Б. Сбойчаков, А.В. Москалев // Медицинские лабораторные технологии: руководство по клинической лабораторной диагностике. – 3-е изд., испр. и доп. – М.: ГЭОТАР-Медиа, 2013. – Т. 2. – С. 513–568.

[4] Assiri, A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study / A. Assiri [et al.] // Lancet Infect. Dis. – 2013. – Vol. 13. – № 9. – P. 752–761.

[5] Assiri, A. Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia /A. Assiri [et al.] // Clin Infect Dis. – 2016. – № 63. – P. 951–953

[6] Behzadi, M.A. Overview of current therapeutics and novel сcandidates аgainst influenza, respiratory syncytial virus, and Middle east respiratory syndrome Coronavirus infections / М.А. Behzadi, V.H. Leyva-Grado // Frontiers in microbiology. – 2019. – № 10. – Р. 1327.

[7] Belouzard, S. Mechanisms of coronavirus cell entry mediated by the viral spike protein / S. Belouzard [et al.] // Viruses. – 2012. – Vol. 4. – P. 1011–1033.

[8] Cauchemez, S. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility / S. Cauchemez [et al.] // Lancet Infect. Dis. – 2014. – Vol. 14, № 1. – P. 50–56.

[9] Chang, H. Feline Infectious Peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene / H. Chang [et al.] // Journal of General Virology. – 2010. – Vol. 9. – P. 415–420.

[10] Chan, K.H. Cross-reactive antibodies in convalescent SARS patients sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests // K.H. Chan [et al.] // J. Infect. – 2013. – Vol. 67. – P. 130–140.

[11] Chan, J.F. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARSlike pandemic? / J.F. Chan [et al.] // J. Infect. – 2012. – Vol. 65. – P. 477–489.

[12] De Groot, R.J. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group / R.J. De Groot [et al.] // J. Virol. – 2013. – Vol. 87. – P. 7790–7792.

[13] Decaro, N. Recombinant Canine Coronaviruses in Dogs / N. Decaro [et al.] // Europe. Emerging Infectious Diseases. – 2013. – Vol. 16, № 1. – P. 41–47.

[14] De Wilde, A.H. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment / A.H. De Wilde [et al.] // J. Gen. Virol. – 2013. – Vol. 94. – P. 1749–1760.

[15] Hashemi-Shahraki, A. Human Middle East Respiratory Syndrome Coronavirus in Bat, South Africa / A. Hashemi-Shahraki [et al.] // Emerg. Infect. Dis. – 2013. – Vol. 19, № 10. – P. 1697–1699.

[16] Hijawi, B. Novel corona-virus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation / B. Hijawi [et al.] // East. Mediterr. Health. J. – 2013. – Vol. 19, № 1. – P. 12–20.

[17] 17.Kenneth, J. Sherris medical microbiology. – sixth edition / J. Kenneth, George Ray C. – New York, 2014. – 994 p.

[18] 18.Mahon, C.R. Diagnostic microbiology, 3rd edh. / C.R. Mahon, C.D. Lehman, G. Manuselis // St. Louis, Missouri: Saunders Elsevier, 2007. – 1211 p.

[19] 19.Meredith, A. Genetics and Pathogenesis of Feline Infectious Peritonitis Virus / A. Meredith [et al.] // Emerging Infectious Diseases. – 2009. – Vol. 15, № 9. – P. 1445– 1452.

[20] 20.Mo Y. Review of treatment modalities for Middle East Respiratory Syndrome / Y. Mo, D.A. Fisher // The Journal of antimicrobial chemotherapy. – 2016. – № 12. – Р. 3340–3350.

[21] 21.Scobey, T. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus / T. Scobey [et al.] // Proc. Natl. Acad. Sci. USA. – 2013. – Vol. 110. – P. 16157–16162.

[22] 22.Rose, N.R. The autoimmune diseases. – fifth edition / N.R. Rose, I.R. Mackay. – Philadelphia, 2018. – 1265 p. 23.Zabriskie, J.B. Essential clinical immunology / J.B. Zabriskie – N. Y., 2009. – 362 p.

RIGHTS & PERMISSIONS

Moskalev A.V., Gumilevskiy B.Y., Apchel V.Y., Cygan V.N.